Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01299675 · ClinicalTrials.gov registry record
SureScan Post-Approval Study
A clinical trial, sponsored by Medtronic.
- Completed
- Registry status
- 2,483
- Enrollment target
NCT01299675 is a clinical trial that has completed, run by Medtronic. The registered enrollment target is 2,483 participants.
The verdict
NCT01299675 has completed, sponsored by Medtronic.
- COMPLETED
- Registry status
- 2,483 participants
- Enrollment target
Study Summary
The purpose of this Post-Approval Study (PAS) is to demonstrate the chronic performance of the SureScan pacing system when used in an MRI environment according to product labeling. This study is required by the Food and Drug Administration (FDA) as a condition of product approval.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,483 participants |
| Start Date | 2011-02-08 |
| Est. Completion | 2017-10-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01299675
The ClinicalTrials.gov registry entry for NCT01299675 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,483 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01299675 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01299675 about?
NCT01299675 is a clinical study titled "SureScan Post-Approval Study". The purpose of this Post-Approval Study (PAS) is to demonstrate the chronic performance of the SureScan pacing system when used in an MRI environment according to product labeling. This study is required by the Food and Drug Administration (FDA) as a condition of product approval.
What is the current status of trial NCT01299675?
This trial is currently completed. The enrollment target is 2,483 participants. The study started on 2011-02-08. Estimated completion is 2017-10-02.
Who is sponsoring clinical trial NCT01299675?
This trial is sponsored by Medtronic, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.